APC and colorectal cancer: Allele-specific RNA interference of APC allows in principle to envisage a patient-specific therapy for colorectal cancer, whereby only cells affected by a mutation in the APC gene will be hampered in their proliferation capacity upon acquisition of a shRNA matching the mutation [41], [42].